Abstract:Obesity, type 2 diabetes and other features of metabolic syndrome are major risk factors for cardiovascular diseases. Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of insulin action. However, the role of PTP1B in obesity-related cardiomyopathy is unknown. This study was designed to evaluate the effect of genetic disruption of PTP1B on cardiac function in diet-induced obesity. Cardiac function was evaluated in Wild-type (WT) and PTP1B-/- mice fed a low fat (10% calorie) or high fat diet (45% calorie) for 5 months. High fat diet intake resulted in larger body weight (41.5±4 vs. 28.2±1g), heart weight (HW) (146±6 vs. 123±6 mg) and glucose intolerance in WT mice, the effect of which was attenuated by PTP1B knockout (n=8-10, p<0.05). Echocardiography showed an increase in wall thickness, end diastolic diameter (2.92±0.16 vs. 2.69±0.08 mm), end systolic diameter (1.73±0.12 vs. 1.33 ±0.06 mm) and a decrease in fractional shortening (39.7±1.4 vs. 51.4 ±2.1) following HFD which were significantly reconciled by PTP1B knockout (n=8-10, p<0.05). In addition, assessment of cardiomyocyte contractile function revealed decreased peak shortening, maximal velocity of shortening and relengthening following HFD feeding, the effect of which was rescued by PTP1B knockout (n=110-120 cells from 3 mice, p<0.05). High fat diet feeding resulted in increased cardiomyocytes cross-sectional area (330±0.05 vs. 233±0.04µm2) and hypertrophic proteins ANP and GATA4, which were significantly attenuated in PTP1B knockout mice (n=3-4 mice, p<0.05). Furthermore, Western blot analysis revealed high fat feeding upregulated Akt and mTOR phosphorylation and decreased AMPK and ACC phosphorylation in WT mice. Interestingly, PTP1B knockout caused a significant increase in phosphorylation of AMPK and ACC without affecting Akt and mTOR phosphorylation. In vitro silencing of PTP1B using siRNA dampened the expression of hypertrophic genes while it promoted AMPK phosphorylation. In conclusion, our data revealed that PTP1B knockout prevented obesity-induced cardiomyopathy by preserving AMPK signaling, suggesting the therapeutic promise of this enzyme in the treatment of obesity-induced cardiac anomalies.

PPA1 Regulates Systemic Insulin Sensitivity by Maintaining Adipocyte Mitochondria Function as a Novel PPARγ Target Gene

Regulation Of Glucose Homeostasis And Lipid Metabolism By Ppp1r3g-Mediated Hepatic Glycogenesis

Ablation of PPP1R3G Reduces Glycogen Deposition and Mitigates High-Fat Diet Induced Obesity.

Adipose Tissue-Specific PPARγ Deficiency Increases Resistance to Oxidative Stress

Peroxisome Proliferator-Activated Receptor Γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization

Protein Tyrosine Phosphatase 1B Inhibits Adipocyte Differentiation and Mediates TNFα Action in Obesity.

Peroxisome Proliferator-Activated Receptor-γ: Master Regulator of Adipogenesis and Obesity

Adipocyte-Specific Ablation of PU.1 Promotes Energy Expenditure and Ameliorates Metabolic Syndrome in Aging Mice

Liver-specific deletion of Ppp2c alpha enhances glucose metabolism and insulin sensitivity

Protective Effects Of Acyl-Coa Thioesterase 1 On Diabetic Heart Via Ppar Alpha/Pgc1 Alpha Signaling

The low molecular weight protein tyrosine phosphatase promotes adipogenesis and subcutaneous adipocyte hypertrophy

Liver-specific deletion of Ppp2cα enhances glucose metabolism and insulin sensitivity.

MYPT1-PP1β phosphatase negatively regulates both chromatin landscape and co-activator recruitment for beige adipogenesis

Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function

A Peroxisome Proliferator-activated Receptor γ (PPARγ)/PPARγ Coactivator 1β Autoregulatory Loop in Adipocyte Mitochondrial Function

Adipocyte Expression of Pu.1 Transcription Factor Causes Insulin Resistance Through Upregulation of Inflammatory Cytokine Gene Expression and Ros Production

Overexpression of PGC-1β Improves Insulin Sensitivity and Mitochondrial Function in 3T3-L1 Adipocytes

PID1 in Adipocytes Modulates Whole-Body Glucose Homeostasis.

MYPT1-PP1β phosphatase negatively regulates both chromatin landscape and co-activator recruitment to influence gene expression during beige adipogenesis

WIP1 phosphatase is a critical regulator of adipogenesis through dephosphorylating PPARγ serine 112

Abstract 15595: Protein Tyrosine Phosphatase 1B Knockout Attenuates Obesity-Induced Cardiomyopathy